Clinical Trial Update: Smartphones to Improve Rivaroxaban ADHEREnce in Atrial Fibrillation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating smartphone use to improve adherence to rivaroxaban in atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Janssen Scientific Affairs, LLC | Conditions: Atrial Fibrillation | Phase 4 | Status: COMPLETED